featured
Off-Label AREDS 2 Supplementation
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Clinical Ophthalmology (Auckland, N.Z.)
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Outcome of Off-Label AREDS 2 Supplementation for the Treatment of Macular Degeneration in Non-Proliferative Idiopathic Type 2 Macular Telangiecta
Clin Ophthalmol 2021 Mar 01;15(15)1133-1143, TA Berger, MW Manry, LB Lindsell, JM Osher, DM Miller, RE Foster, CD Riemann, MR Petersen, RA SiskFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.